Comments

Inhibikase Therapeutics Stock News

IKTNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$1.53
-0.085-5.25%
Last update: Dec 16, 10:29 AM
Overview

News

EarningsAnalyst RatingsInsider TradesShort InterestStock Report

Latest Inhibikase Therapeutics Stock News | NASDAQ:IKT | Benzinga

Get the latest news on Inhibikase Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Inhibikase Therapeutics performance

People Also Watch

Cabaletta Bio Inc
NASDAQ:CABA
$2.47
3.35%
Innate Pharma SA
NASDAQ:IPHA
$1.90
1.06%
Humacyte Inc
NASDAQ:HUMA
$1.18
-0.38%
Burning Rock Biotech Ltd
NASDAQ:BNR
$15.90
11.36%
Armata Pharmaceuticals Inc
AMEX:ARMP
$6.00
-2.60%
Vistagen Therapeutics Inc
NASDAQ:VTGN
$4.45
1.37%
Enlivex Therapeutics Ltd
NASDAQ:ENLV
$0.86
-0.41%
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
$19.05
1.01%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved